» Articles » PMID: 38722595

Identification of Clonal Hematopoiesis Driver Mutations Through In Silico Saturation Mutagenesis

Overview
Journal Cancer Discov
Specialty Oncology
Date 2024 May 9
PMID 38722595
Authors
Affiliations
Soon will be listed here.
Abstract

Clonal hematopoiesis (CH) is a phenomenon of clonal expansion of hematopoietic stem cells driven by somatic mutations affecting certain genes. Recently, CH has been linked to the development of hematologic malignancies, cardiovascular diseases, and other conditions. Although the most frequently mutated CH driver genes have been identified, a systematic landscape of the mutations capable of initiating this phenomenon is still lacking. In this study, we trained machine learning models for 12 of the most recurrent CH genes to identify their driver mutations. These models outperform expert-curated rules based on prior knowledge of the function of these genes. Moreover, their application to identify CH driver mutations across almost half a million donors of the UK Biobank reproduces known associations between CH driver mutations and age, and the prevalence of several diseases and conditions. We thus propose that these models support the accurate identification of CH across healthy individuals. Significance: We developed and validated gene-specific machine learning models to identify CH driver mutations, showing their advantage with respect to expert-curated rules. These models can support the identification and clinical interpretation of CH mutations in newly sequenced individuals. See related commentary by Arends and Jaiswal, p. 1581.

Citing Articles

Prognostic impact of TET2 mutations in patients with acute myeloid leukemia: HM-SCREEN-Japan 01 and 02 study.

Iyama S, Chi S, Idogawa M, Ikezoe T, Fukushima K, Utsu Y Ann Hematol. 2025; 104(1):275-284.

PMID: 39921715 PMC: 11868205. DOI: 10.1007/s00277-025-06227-y.

References
1.
Khoury J, Solary E, Abla O, Akkari Y, Alaggio R, Apperley J . The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia. 2022; 36(7):1703-1719. PMC: 9252913. DOI: 10.1038/s41375-022-01613-1. View

2.
Hagiwara K, Natarajan S, Wang Z, Zubair H, Mulder H, Dong L . Dynamics of Age- versus Therapy-Related Clonal Hematopoiesis in Long-term Survivors of Pediatric Cancer. Cancer Discov. 2023; 13(4):844-857. PMC: 10070170. DOI: 10.1158/2159-8290.CD-22-0956. View

3.
Hsu J, Dayaram T, Tovy A, De Braekeleer E, Jeong M, Wang F . PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy. Cell Stem Cell. 2018; 23(5):700-713.e6. PMC: 6224657. DOI: 10.1016/j.stem.2018.10.004. View

4.
Calvillo-Arguelles O, Jaiswal S, Shlush L, Moslehi J, Schimmer A, Barac A . Connections Between Clonal Hematopoiesis, Cardiovascular Disease, and Cancer: A Review. JAMA Cardiol. 2019; 4(4):380-387. DOI: 10.1001/jamacardio.2019.0302. View

5.
Kotler E, Shani O, Goldfeld G, Lotan-Pompan M, Tarcic O, Gershoni A . A Systematic p53 Mutation Library Links Differential Functional Impact to Cancer Mutation Pattern and Evolutionary Conservation. Mol Cell. 2018; 71(1):178-190.e8. DOI: 10.1016/j.molcel.2018.06.012. View